BNT162b2 #LP81 early #vaccine #effectiveness against #COVID19 emergency department, urgent care, and outpatient visits, https://etidiohnew.blogspot.com/2026/05/bnt162b2-lp81-early-vaccine.html
#Effectiveness of BNT162b2 #LP81-adapted #SARS-CoV-2 #vaccine against #COVID19 associated #hospitalisation and #death: a Danish nationwide cohort study, https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00236-7/fulltext?rss=yes
In summary, in this nationwide, registry-based cohort study of adults aged 65 years and older in Denmark, we found that the BNT162b2 LP.8.1-adapted vaccine offered good protection over a 4-month period against COVID-19 hospitalisation and death.
